Erythropoietin resistance in the treatment of the anemia of chronic renal failure.
Resistance to erythropoietin therapy is a common complication of the modern management of anemia in chronic kidney disease. Iron deficiency, deficiency of other nutrients, toxins, infections, and inadequate dialysis account for the vast majority of episodes of such resistance.
Priyadarshi
Anumeet
A
Department of Medicine, Medical University of Ohio, Toledo, Ohio 43614-5089, USA.
Shapiro
Joseph I
JI
D000740:Anemia / Q000209:etiology / Q000628:therapy*; D004351:Drug Resistance; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D011994:Recombinant Proteins; D006435:Renal Dialysis
D011994:Recombinant Proteins; D004921:Erythropoietin